Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
news
5th International Symposium, New Frontiers in Cardiovascular Research
Pharmahungary Group scientific management team has attended the 5th International Symposium, New Frontiers in Cardiovascular Research in Sapporo, Japan
news
It is with great sadness that we announce the passing of Jacques van Rooyen, PhD
It is with great sadness that we announce the passing of Jacques van Rooyen, PhD
news
Clinical trials with Medical Devices. Good Clinical Practice lecture by Clinical Director
Clinical trials with Medical Devices. Good Clinical Practice lecture by Clinical Director
news
EU-CARDIOPROTECTION co-chaired by Pharmahungary Group Founder & CEO
Realising the therapeutic potential of novel cardioprotective therapies, COST Action